Andere talen ReproCELL Incorporated

Aandelen

4978

JP3974770004

Vertraagde tijd Japan Exchange Andere beurzen 08:00:00 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
133 ^JPY	-0,75%		-2,21%	-24,00%

2023	ReproCELL Incorporated meldt winstresultaten voor het gehele jaar eindigend op 31 maart 2023	CI
2022	REPROCELL ondertekent overeenkomst om prospectief stalen te verzamelen voor IFF's Microbiome Studie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	21/12
ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	05/12
ReproCELL Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023	12-05-23
Clinical Trials: An Evolutionary Perspective	18-01-23
Histocell, S.L. announced that it expects to receive ?0.4 million in funding from ReproCELL Incorporated	08-11-22
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing	01-11-22
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval	17-08-22
ReproCELL Incorporated : Everything we know about the 5HT1B receptor	21-04-22
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study	20-04-22
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods	29-03-22
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease	18-03-22
ReproCELL Incorporated : What is Human Tissue Testing?	14-03-22
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development	08-03-22
ReproCELL Incorporated : Solutions for Skin Disease Researchers	04-03-22
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin	03-03-22
ReproCELL Incorporated : How SynFire® Technology can benefit your research	03-03-22
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?	28-02-22
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems	15-02-22
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting	10-02-22
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex	07-02-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ReproCELL Incorporated

Aandelen

4978

JP3974770004

Andere talen

Filters